SOURCE: Law Offices of Robert H. Weiss, PLLC

February 26, 2009 14:42 ET

Robert Weiss of The Law Offices of Robert H. Weiss Testifies Before the FDA Science Board on Bisphenol-A

JERICHO, NY--(Marketwire - February 26, 2009) - On February 24, 2009, the FDA convened a meeting of the Science Board to hear about and discuss updates from the agency on the continued assessment of Bisphenol-A (BPA) in FDA-regulated products. Committed to the fight to protect our infants and children from the harmful effects of BPA, Robert Weiss spoke before the Science Board and demanded a call to action. Mr. Weiss asked the FDA to take immediate action to regulate BPA. "Baby bottle manufacturers must be required to immediately remove and recall all baby bottles, toddler training cups, and other infant products containing BPA as infants and young children of America continue to be subjected to toxic levels of BPA. We cannot wait... any delay in action will inevitably result in injuries to our children and future generations."

In March 2007, Robert Weiss filed the first class action case against baby bottle manufacturers for their use of Bisphenol-A in baby bottles and toddler-sippy cups. At the time, there were hundreds of independent peer-reviewed scientific studies that demonstrated a wide range of adverse effects to laboratory animals as a result of low-dose exposures to BPA. Nearly two years later, scores of additional low dose exposure studies have been published which further confirms a very real increased risk not only to humans in the general population, but to infants and children who are especially vulnerable to the effects of exposure to BPA.

BPA is classified as an endocrine disruptor, which can interfere with or disrupt the finely orchestrated balance of hormones that are active during critical periods of the development and formation of the brain and sexual organs in the fetus, infants or young children who have been identified as being particularly vulnerable and therefore are at an even greater risk to the harmful effects of BPA. Experts have also compared BPA to diethylstilbestrol, otherwise known as "DES," a drug prescribed to thousands of women to combat the effects of nausea during pregnancy. Research now shows that DES has caused injury to generations of children whose mothers were given this drug.

Robert H. Weiss is committed to protecting our infants and will not stop until the infants of America are no longer used as laboratory subjects for testing the safety of high volume chemicals like BPA. If you have any questions or concerns, feel free to contact our office at (516) 876-4213.